Integration of genome and chromatin structure with gene expression profiles to predict c-MYC recognition site binding and function

PLoS Computational Biology

Volumn 3, Issue 4, 2007, Pages 602-615

  Chen, Yili ^a   Blackwell, Thomas W ^a   Chen, Ji ^a   Gao, Jing ^a   Lee, Angel W ^a   States, David J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ALKYLATION; BAYESIAN NETWORKS; BINDING SITES; C (PROGRAMMING LANGUAGE); COMPUTATION THEORY; COMPUTATIONAL METHODS; DNA; FORECASTING; METHYLATION; PROTEINS; TRANSCRIPTION;

CHROMATIN STRUCTURE; COMPUTATIONAL MODELLING; DNA METHYLATION; GENE EXPRESSION PROFILES; GENES ENCODE; GENOME STRUCTURES; GENOMICS; RECOGNITION SITE; SITE BINDING; SPECIFIC BINDING;

GENOME;

BINDING PROTEIN; GENOMIC DNA; MYC PROTEIN; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; MYCBP PROTEIN, HUMAN;

ACETYLATION; ALGORITHM; ARTICLE; BAYES THEOREM; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SEQUENCE; GENE STRUCTURE; GENOME; MATHEMATICAL MODEL; MOLECULAR RECOGNITION; PREDICTION; PROBABILITY; BIOLOGICAL MODEL; CHEMICAL MODEL; CHEMISTRY; CHROMATIN; CHROMOSOME MAP; COMPUTER SIMULATION; GENETICS; METHODOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; SYSTEM ANALYSIS;

BINDING SITES; CHROMATIN; CHROMOSOME MAPPING; COMPUTER SIMULATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SEQUENCE ANALYSIS, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; SYSTEMS INTEGRATION; TRANSCRIPTION FACTORS;

EID: 34247641243     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0030063     Document Type: Article

References (59)

1. Amati B, Frank SR, Donjerkovic D, Taubert S (2001) Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 1471: M135-M145.
2. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11.
3. Dang CV, Resar LM, Emison E, Kim S, Li Q, et al. (1999) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253: 63-77.
4. Ben-Yosef T, Yanuka O, Halle D, Benvenisty N (1998) Involvement of Myc targets in c-Myc and N-Myc induced human tumors. Oncogene 17: 165-171.
5. Facchini LM, Penn LZ (1998) The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights. Faseb J 12: 633-651.
6. Gartel AL, Shchors K (2003) Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 283: 17-21.
7. Mao DY, Watson JD, Yan PS, Barsyte-Lovejoy D, Khosravi F, et al. (2003) Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol 13: 882-886.
8. Papoulas O, Williams NG, Kingston RE (1992) DNA binding activities of c-Myc purified from eukaryotic cells. J Biol Chem 267: 10470-10480.
9. Swanson HI, Yang JH (1999) Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site. Nucleic Acids Res 27: 3205-3212.
10. Guo QM, Malek RL, Kim S, Chiao C, He M, et al. (2000) Identification of c-Myc responsive genes using rat cDNA microarray. Cancer Res 60: 5922-5928.
11. Watson JD, Oster SK, Shago M, Khosravi F, Penn LZ (2002) Identifying genes regulated in a Myc-dependent manner. J Biol Chem 277: 36921-36930.
12. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, et al. (2003) A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278: 12563-12573.
13. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, et al. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 100: 8164-8169.
14. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, et al. (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390.
15. Remondini D, O'Connell B, Intrator N, Sedivy JM, Neretti N, et al. (2005) Targeting c-Myc-activated genes with a correlation method: Detection of global changes in large gene expression network dynamics. Proc Natl Acad Sci U S A 102: 6902-6906.
16. Schuldiner O, Shor S, Benvenisty N (2002) A computerized database-scan to identify c-MYC targets. Gene 292: 91-99.
17. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV (2003) An integrated database of genes responsive to the Myc oncogenic transcription factor: Identification of direct genomic targets. Genome Biol 4: R69.
18. Haggerty TJ, Zeller KI, Osthus RC, Wonsey DR, Dang CV (2003) A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc Natl Acad Sci U S A 100: 5313-5318.
19. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, et al. (2003) Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129.
20. Clark SJ, Harrison J, Frommer M (1995) CpNpG methylation in mammalian cells. Nat Genet 10: 20-27.
21. Bird A, Taggart M, Frommer M, Miller OJ, Macleod D (1985) A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40: 91-99.
22. Prendergast GC, Ziff EB (1991) Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251: 186-189.
23. Perini G, Diolaiti D, Porro A, Della Valle G (2005) In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci U S A 102: 12117-12122.
24. Khorasanizadeh S (2004) The nucleosome: From genomic organization to genomic regulation. Cell 116: 259-272.
25. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, et al. (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764-770.
26. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci U S A 102: 4459-4464.
27. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, et al. (2006) DNA methylation profiling of human chromosomes 6, 20, and 22. Nat Genet 38: 1378-1385.
28. Wingender E, Dietze P, Karas H, Knuppel R (1996) TRANSFAC: A database on transcription factors and their DNA binding sites. Nucleic Acids Res 24: 238-241.
29. Solomon DL, Amati B, Land H (1993) Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res 21: 5372-5376.
30. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91-D94.
31. Lenhard B, Wasserman WW (2002) TFBS: Computational framework for transcription factor binding site analysis. Bioinformatics 18: 1135-1136.
32. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, et al. (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
33. Roh TY, Cuddapah S, Zhao K (2005) Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 19: 542-552.
34. Ian H, Witten EF (2005) Data mining: Practical machine learning tools and techniques. San Francisco: Morgan Kaufmann. 525 p.
35. Zeller KI, Zhao X, Lee CW, Chiu KP, Yao F, et al. (2006) Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A 103: 17834-17839.
36. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, et al. (2004) Unbiased mapping of transcription factor binding sites along human Chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509.
37. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, et al. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1: 203-209.
38. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80.
39. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
40. Tamura K, Hua B, Adachi S, Guney I, Kawauchi J, et al. (2005) Stress response gene ATF3 is a target of c-Myc in serum-induced cell proliferation. EMBO J 24: 2590-2601.
41. Teng SC, Chen YY, Su YN, Chou PC, Chiang YC, et al. (2004) Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem 279: 14649-14655.
42. Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, et al. (1996) ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc Natl Acad Sci U S A 93: 7143-7148.
43. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, et al. (1994) Repression of cyclin D1: A novel function of MYC. Mol Cell Biol 14: 4032-4043.
44. Freytag SO, Geddes TJ (1992) Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 256: 379-382.
45. Yang BS, Gilbert JD, Freytag SO (1993) Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol Cell Biol 13: 3093-3102.
46. Oster SK, Marhin WW, Asker C, Facchini LM, Dion PA, et al. (2000) Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol Cell Biol 20: 6768-6778.
47. Taira T, Sawai M, Ikeda M, Tamai K, Iguchi-Ariga SM, et al. (1999) Cell cycle-dependent switch of up- and down-regulation of human hsp70 gene expression by interaction between c-Myc and CBF/NF-Y. J Biol Chem 274: 24270-24279.
48. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, et al. (2006) The c-Myc target gene network. Semin Cancer Biol 16: 253-264.
49. Gardiner-Garden M, Frommer M (1987) CpG islands in vertebrate genomes. J Mol Biol 196: 261-282.
50. Cross SH, Charlton JA, Nan X, Bird AP (1994) Purification of CpG islands using a methylated DNA binding column. Nat Genet 6: 236-244.
51. Cross SH, Clark VH, Simmen MW, Bickmore WA, Maroon H, et al. (2000) CpG island libraries from human Chromosomes 18 and 22: Landmarks for novel genes. Mamm Genome 11: 373-383.
52. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300.
53. Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L, et al. (2004) In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc Natl Acad Sci U S A 101: 615-620.
54. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22: 2790-2799.
55. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, et al. (2003) Gene expression predictors of breast cancer outcomes. Lancet 361: 1590-1596.
56. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98: 13790-13795.
57. Crossman LC, Mori M, Hsieh YC, Lange T, Paschka P, et al. (2005) In chronic myeloid leukemia white cells from cytogenetic responders and non-responders to imatinib have very similar gene expression signatures. Haematologica 90: 459-464.
58. Cheok MH, Yang W, Pui CH, Downing JR, Cheng C, et al. (2003) Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat Genet 34: 85-90.
59. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.